Clinical Evaluation Of Different Doses Of Single Sialic Acid Four Hexose Ganglioside Sodium

Objective: To observe the single saliva has four sugar ganglion glucoside ester to treat acute cerebral hemorrhage,cerebral infarction,diabetes,peripheral nerve and the clinical curative effect and adverse reaction of brain hemorrhage.To explore the efficiency and safety of the treatment,so as to provide scientific basis for standard treatment.Methods: Collecting cases from February 2013 to March 2013 that are ill with acute cerebral hemorrhage,acute cerebral infarction,cerebral injury cases,diabetes peripheral neurophaty.Then observing clinical curative effect and adverse reactions before and after cases.Results: The total effective rate of this group was obviously higher than that of control group(P<0.05).This set of NBNA score after treatment compared with control group increased significantly(P<0.05).Analysis results show that compared to placebo treatment of Parkinson's disease to improve motor function score.Patients serum CK-BB observation group was obviously lower than the control group.Good recovery rate in observation group(17/30)compared with control group(8/30),the difference was statistically significant(P<0.05).Single sialic acid four hexose ganglion side has good clinical curative effect,the incidence of adverse reactions was 5.43%(5/92),which has nothing to do with the dosage.Conclusion: To improve the Parkinson's patients,acute cerebral infarction,craniocerebral injury,diabetic peripheral neuropathy patients effectively.It has mild adverse reactions in the treatment process.For lack of the experimental study,and there are some defects,this research result has some uncertainty.Therefore,the conclusion remains to be further confirmed by random experiments.